Sales rise 59.54% to Rs 4.85 crore
Net profit of Beryl Drugs declined 16.67% to Rs 0.10 crore in the quarter ended June 2017 as against Rs 0.12 crore during the previous quarter ended June 2016. Sales rose 59.54% to Rs 4.85 crore in the quarter ended June 2017 as against Rs 3.04 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales4.853.04 60 OPM %5.579.54 -PBDT0.230.24 -4 PBT0.130.14 -7 NP0.100.12 -17Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
